» Articles » PMID: 39778405

Pituitary Abnormalities in Patients with Pediatric Growth Hormone Deficiency in a Single Tertiary Center

Overview
Date 2025 Jan 8
PMID 39778405
Authors
Affiliations
Soon will be listed here.
Abstract

Purpose: There is controversy as to whether brain magnetic resonance imaging (MRI) should be performed on all children with growth hormone deficiency (GHD) including those judged to have mild GHD. This study was aimed to determine the frequency of pituitary or intracranial abnormalities in pediatric GHD and to identify risk factors that may predict pituitary or intracranial abnormalities.

Methods: A total of 95 pediatric GHD patients were included. Their medical records and brain magnetic resonance (MR) images were reviewed retrospectively.

Results: Abnormal pathogenic MR images were found in 14 patients (14.7%), including 10 (10.5%) with pituitary hypoplasia and 4 (4.2%) with pituitary stalk interruption syndrome. Serum levels of insulin-like growth factor-I (IGF-I), IGF-I standard deviation score (SDS), insulin-like growth factor binding protein 3 (IGFBP3), and growth hormone (GH) peak level of GH stimulation test were statistically significantly lower in the group with abnormal brain MRI. The frequency of abnormal MRI was statistically significantly higher in the complete GHD group. IGF-1 SDS showed the highest area under the curve which can predict the presence of brain abnormality with a sensitivity of 85% and a specificity of 71.4%, if IGF-1 SDS was less than -1.365. IGF-1, IGFBP3, and GH peak levels also showed good sensitivity of over 80% for predicting brain abnormalities with cutoff values of 70.285 ng/mL, 1,604 ng/mL, and 4.205 ng/mL, respectively.

Conclusion: The sensitivity and specificity of each cutoff value of IGF-1, IGF-1 SDS, IGFBP3, and GH peak levels were good and statistically significant in predicting brain MRI abnormalities. However, it was insufficient to predict all brain abnormalities with these variables. Therefore, we would like to recommend performing a brain MRI if a child is diagnosed with GHD.

References
1.
Sims N, Clement-Lacroix P, Da Ponte F, Bouali Y, Binart N, Moriggl R . Bone homeostasis in growth hormone receptor-null mice is restored by IGF-I but independent of Stat5. J Clin Invest. 2000; 106(9):1095-103. PMC: 301420. DOI: 10.1172/JCI10753. View

2.
Clemmons D . Value of insulin-like growth factor system markers in the assessment of growth hormone status. Endocrinol Metab Clin North Am. 2007; 36(1):109-29. DOI: 10.1016/j.ecl.2006.11.008. View

3.
Rinderknecht E, HUMBEL R . The amino acid sequence of human insulin-like growth factor I and its structural homology with proinsulin. J Biol Chem. 1978; 253(8):2769-76. View

4.
Maghnie M, Ghirardello S, Genovese E . Magnetic resonance imaging of the hypothalamus-pituitary unit in childrensuspected of hypopituitarism: who, how and when toinvestigate. J Endocrinol Invest. 2004; 27(5):496-509. DOI: 10.1007/BF03345298. View

5.
Alba P, Tsai S, Mitre N . The Severity of Growth Hormone Deficiency Does Not Predict the Presence or Absence of Brain Magnetic Resonance Imaging Abnormalities - A Retrospective Review. Eur Endocrinol. 2020; 16(1):60-64. PMC: 7308106. DOI: 10.17925/EE.2020.16.1.60. View